Patient characteristics | All (n=240) | Tenting area/BSA | Tenting area/annulus diameter | Gender differences | ||||||
>1.35 cm2/m2 (n=129) | ≤1.35 cm2/m2 (n=111) | P value | >0.76 cm2/cm (n=92) | ≤0.76 cm2/cm (n=148) | P value | Females (n=105) | Males (n=135) | P value | ||
Male (%) | 135 (56.3) | 72 (55.8) | 63 (56.8) | 0.88 | 53 (55.4) | 82 (57.6) | 0.74 | – | – | – |
Age (years) | 68.0±9.8 | 67.5±9.8 | 68.4±9.7 | 0.59 | 67.1±10.1 | 68.4±4.3 | 0.33 | 68.1±9.8 | 67.2±8.2 | 0.17 |
BSA (m2) | 1.9±0.2 | 1.9±0.2 | 2.0±0.2 | 0.04 | 2.0±0.2 | 1.9±0.2 | 0.37 | 1.8±0.2 | 2.0±0.1 | <0.001 |
Diabetes (%) | 44 (18.3) | 24 (18.2) | 20 (18.6) | 0.93 | 18 (17.7) | 26 (19.6) | 0.72 | 16 (15.2) | 28 (20.9) | 0.24 |
Creatinine (mg/dL) | 1.3±0.8 | 1.4±1.0 | 1.2±0.6 | 0.11 | 1.4±1.0 | 1.3±0.7 | 0.31 | 1.3±0.5 | 1.3±0.7 | 0.96 |
CAD (%) | 127 (52.9) | 66 (51.6) | 61 (55.0) | 0.56 | 51 (55.4) | 76 (51.4) | 0.54 | 37 (35.2) | 90 (66.7) | <0.001 |
Acute HF (%) | 107 (44.6) | 66 (51.6) | 41 (36.9) | 0.02 | 45 (49.5) | 62 (41.9) | 0.25 | 46 (43.8) | 61 (45.5) | 0.79 |
LVEF (%) | 46±12 | 44±12 | 49±12 | 0.01 | 43±13 | 48±12 | 0.04 | 49±11 | 44±13 | 0.04 |
Ischaemic CM | 135 (56.3) | 73 (56.6) | 62 (55.9) | 0.91 | 78 (52.7) | 57 (62) | 0.16 | 42 (40) | 93 (68.9) | <0.001 |
Non-ischaemic CM | 105 (43.7) | 56 (43.4) | 49 (44.1) | 0.91 | 70 (47.3) | 35 (38) | 0.16 | 63 (60) | 42 (31.1) | <0.001 |
STS Score (%) | 3.4±3.5 | 3.5±3.9 | 3.2±3.0 | 0.58 | 3.2±2.4 | 3.4±4.0 | 0.68 | 3.6±4.5 | 3.2±3.5 | 0.33 |
EuroSCORE II (%) | 7.1±8.9 | 7.0±8.5 | 7.3±9.4 | 0.83 | 7.5±8.9 | 6.9±8.9 | 0.65 | 7.4±9.9 | 7.0±8.2 | 0.71 |
Ring size (mm) | 29.9±1.6 | 29.9±1.8 | 30.0±1.7 | 0.69 | 30.0±1.8 | 29.9±1.7 | 0.64 | 29.3±1.6 | 30.5±1.7 | <0.001 |
Concomit. proc. (%) | 184 (76.7) | 97 (75.2) | 87 (78.4) | 0.56 | 67 (79.1) | 117 (72.8) | 0.76 | 71 (67.6) | 113 (83.7) | 0.003 |
CABG (%) | 94 (39.2) | 41 (31.8) | 53 (47.7) | 0.01 | 33 (35.9) | 61 (41.2) | 0.41 | 23 (21.9) | 71 (52.6) | <0.001 |
Continuous values presented means±SD; categorial values presented as no. (%).
Acute HF, decompensated heart failure within two weeks before surgery; BSA, body surface area (m2); CABG, coronary artery bypass grafting; CAD, Coronary artery disease; CM, cardiomyopathy; LVEF, left ventricle ejection fraction; STS Score, Society of Thoracic Surgery risk score for mortality.